Reaction
Malacoplakia reporting signals
As of the last recalculation, Malacoplakia appears in 387 FAERS reports alongside 17 co-occurring drug terms. The strongest observed disproportionality signal is TACROLIMUS OINTMENT 0.1% (PRR 1,047.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Tacrolimus Ointment 0.1% | 334 | 1,047.0 | 1,049.8 |
| Tacrolimus Extended-Release Capsules | 334 | 1,044.2 | 1,047.0 |
| Tacrolimus | 341 | 977.7 | 979.8 |
| Mycophenilic Acid | 69 | 217.7 | 218.4 |
| Mycophenolate Mofetil | 227 | 216.0 | 216.4 |
| Mycophenolate Mofetil Hydrochloride | 227 | 215.6 | 216.0 |
| Basiliximab | 42 | 215.3 | 216.1 |
| Atovaquone | 28 | 201.6 | 202.3 |
| Mycophenolic Acid | 78 | 163.9 | 164.3 |
| Valganciclovir Hydrochloride Powder, | 33 | 159.0 | 159.4 |
| Valganciclovir | 34 | 106.2 | 106.4 |
| Valganciclovir Hydrochloride | 34 | 106.2 | 106.4 |
| Anti-Thymocyte Globulin (Rabbit) | 13 | 89.6 | 89.8 |
| Everolimus Tablets | 18 | 60.5 | 60.6 |
| Sirolimus | 14 | 57.9 | 58.0 |
| Cefepime | 9 | 34.5 | 34.6 |
| Cefepime Hydrochloride | 9 | 30.7 | 30.8 |